Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Bank of New York Mellon Corp
> AKBA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Akebia Therapeutics, Inc. | AKBA | 71,836 | 0 | 65,730,000 | 25,473,000 | $915.00 |
03/31/2023 | Akebia Therapeutics, Inc. | AKBA | 71,836 | 0 | 40,257,000 | -1,192,000 | $560.40 |
12/31/2022 | Akebia Therapeutics, Inc. | AKBA | 71,836 | 71,836 | 41,449,000 | 41,449,000 | $576.99 |
09/30/2022 | Akebia Therapeutics, Inc. | AKBA | 0 | -71,836 | 0 | -26,000 | |
06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 71,836 | -567,047 | 26,000 | -433,000 | $0.36 |
03/31/2022 | Akebia Therapeutics, Inc. | AKBA | 638,883 | 14,038 | 459,000 | -954,000 | $0.72 |
12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 624,845 | 33,016 | 1,413,000 | -291,000 | $2.26 |
09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 591,829 | 29,674 | 1,704,000 | -426,000 | $2.88 |
06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 562,155 | -95,756 | 2,130,000 | 287,000 | $3.79 |
03/31/2021 | Akebia Therapeutics, Inc. | AKBA | 0 | -657,911 | 0 | -1,843,000 | |
12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 657,911 | 79,885 | 1,843,000 | 393,000 | $2.80 |
09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 578,026 | -53,282 | 1,450,000 | -7,123,000 | $2.51 |
06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 631,308 | 40,206 | 8,573,000 | 4,093,000 | $13.58 |
03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 591,102 | -101,256 | 4,480,000 | 104,000 | $7.58 |
12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 692,358 | 23,801 | 4,376,000 | 1,755,000 | $6.32 |
09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 668,557 | -4,317 | 2,621,000 | -635,000 | $3.92 |
06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 672,874 | 118,881 | 3,256,000 | -1,281,000 | $4.84 |
03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 553,993 | 5,398 | 4,537,000 | 1,503,000 | $8.19 |
12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 548,595 | 333,569 | 3,034,000 | 1,136,000 | $5.53 |
09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 215,026 | 306 | 1,898,000 | -245,000 | $8.83 |
06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 214,720 | 14,089 | 2,143,000 | 232,000 | $9.98 |
03/31/2018 | Akebia Therapeutics, Inc. | AKBA | 200,631 | -50,762 | 1,911,000 | -1,826,000 | $9.52 |
12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 251,393 | 27,408 | 3,737,000 | -669,000 | $14.87 |
09/30/2017 | Akebia Therapeutics, Inc. | AKBA | 223,985 | 24,167 | 4,406,000 | 1,534,000 | $19.67 |
06/30/2017 | Akebia Therapeutics, Inc. | AKBA | 199,818 | 53,012 | 2,872,000 | 1,522,000 | $14.37 |
03/31/2017 | Akebia Therapeutics, Inc. | AKBA | 146,806 | -976 | 1,350,000 | -189,000 | $9.20 |
12/31/2016 | Akebia Therapeutics, Inc. | AKBA | 147,782 | 20,325 | 1,539,000 | 385,000 | $10.41 |
09/30/2016 | Akebia Therapeutics, Inc. | AKBA | 127,457 | 127,457 | 1,154,000 | 1,154,000 | $9.05 |
06/30/2016 | Akebia Therapeutics, Inc. | AKBA | 129,975 | 9,982 | 971,000 | -110,000 | $7.47 |
03/31/2016 | Akebia Therapeutics, Inc. | AKBA | 119,993 | -29,370 | 1,081,000 | -849,000 | $9.01 |
12/31/2015 | Akebia Therapeutics, Inc. | AKBA | 149,363 | 3,213 | 1,930,000 | 518,000 | $12.92 |
09/30/2015 | Akebia Therapeutics, Inc. | AKBA | 146,150 | 74,596 | 1,412,000 | 676,000 | $9.66 |
06/30/2015 | Akebia Therapeutics, Inc. | AKBA | 71,554 | 42,938 | 736,000 | -59,000 | $10.29 |
03/31/2015 | Akebia Therapeutics, Inc. | AKBA | 34,914 | -25 | 388,000 | -18,000 | $11.11 |
12/31/2014 | Akebia Therapeutics, Inc. | AKBA | 34,939 | 4,861 | 406,000 | -259,000 | $11.62 |
<< Prev Next >> |
|